Balyasny Asset Management’s Vaxart VXRT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-48,980
Closed -$63.7K 3159
2024
Q1
$63.7K Buy
+48,980
New +$51.3K ﹤0.01% 2516
2023
Q3
Sell
-29,138
Closed -$21.3K 2766
2023
Q2
$21.3K Buy
+29,138
New +$27.1K ﹤0.01% 2156
2023
Q1
Sell
-21,235
Closed -$20.4K 3199
2022
Q4
$20.4K Sell
21,235
-32,040
-60% -$45.3K ﹤0.01% 2479
2022
Q3
$116K Buy
+53,275
New +$184K ﹤0.01% 2392
2020
Q3
Sell
-106,425
Closed -$942K 1631
2020
Q2
$942K Buy
+106,425
New +$306K 0.01% 836

Other funds holding VXRT

Balyasny Asset Management's VXRT Position: Q2 2024 in Review

Balyasny Asset Management sold out of Vaxart (VXRT) in Q2 2024, closing a stake of 48,980 shares — an estimated $63.7K sold.

Balyasny Asset Management first reported a position in VXRT in Q2 2020 and held it in 5 quarters. The position peaked at $942K in Q2 2020. 100 funds tracked by Wall St. Rank hold VXRT as of Q2 2024.

  • Balyasny Asset Management reported no remaining Vaxart position as of Q2 2024 after selling out during the quarter.
  • Balyasny Asset Management sold 48,980 Vaxart shares in Q2 2024, an estimated $63.7K.
  • Balyasny Asset Management first reported a position in Vaxart in Q2 2020 and held it in 5 quarters.
  • Balyasny Asset Management's Vaxart position peaked at $942K in Q2 2020.
  • 100 funds tracked by Wall St. Rank held Vaxart as of Q2 2024.

Based on Balyasny Asset Management's 13F filing for Q2 2024, filed 14 Aug 2024.